Differential Methylation of Chronic Obstructive Pulmonary Disease Lung Macrophage Genes Sheds Light on Disease Pathogenesis

Iain R Konigsberg,Ivana V Yang,Iain R. Konigsberg,Ivana V. Yang
DOI: https://doi.org/10.1165/rcmb.2022-0125ED
IF: 7.748
2022-06-02
American Journal of Respiratory Cell and Molecular Biology
Abstract:Altered DNA methylation has been implicated in a variety of human diseases, including respiratory diseases such as asthma, idiopathic pulmonary fibrosis, and chronic obstructive pulmonary disease (COPD) (1). DNA methylation, which involves the reversible transfer of a methyl group to the fifth carbon of a cytosine nucleotide followed by a guanine (CpG; p is for the phosphate connecting the bases!), can impact gene expression through mechanisms such as altering local chromatin landscape and recruiting or blocking relevant transcription factors at the locus. Illumina has developed successive genotyping-based arrays to assay methylation at CpGs across the genome. The most recent platform, the EPIC chip, assays ∼850,000 CpGs with a focus on regulatory elements and CpG islands. These clusters of CpGs often overlap with gene promoters, show variable methylation, and often show an inverse correlation between methylation concentrations and the expression of related genes. Profiling the methylome allows for biological discovery as well as the identification of biomarkers related to the disease. Furthermore, modification of methylation of specific genomic regions is of major interest for pharmaceutical development, and we've seen the first wave of epigenetic therapeutics emerge (2).
biochemistry & molecular biology,cell biology,respiratory system
What problem does this paper attempt to address?